Rock Springs Capital Management as of Sept. 30, 2016
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 137 positions in its portfolio as reported in the September 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Tesaro | 3.9 | $63M | 627k | 100.24 | |
Aetna | 3.2 | $51M | 440k | 115.45 | |
Radius Health | 3.0 | $48M | 892k | 54.09 | |
Acadia Healthcare (ACHC) | 2.9 | $46M | 925k | 49.55 | |
Gw Pharmaceuticals Plc ads | 2.7 | $43M | 325k | 132.73 | |
Allergan | 2.7 | $43M | 186k | 230.31 | |
Spark Therapeutics | 2.4 | $38M | 625k | 60.06 | |
Merck & Co (MRK) | 2.3 | $37M | 588k | 62.41 | |
Pfizer (PFE) | 2.2 | $36M | 1.1M | 33.87 | |
Advanced Accelerat spon ads each rep 2 ord | 2.2 | $35M | 930k | 38.08 | |
Alexion Pharmaceuticals | 2.0 | $33M | 267k | 122.54 | |
Intuitive Surgical (ISRG) | 2.0 | $33M | 45k | 724.82 | |
Hca Holdings (HCA) | 2.0 | $33M | 430k | 75.63 | |
CIGNA Corporation | 1.9 | $30M | 229k | 130.32 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.9 | $30M | 1.5M | 19.26 | |
WellCare Health Plans | 1.7 | $28M | 235k | 117.09 | |
Gilead Sciences (GILD) | 1.7 | $27M | 344k | 79.12 | |
Celgene Corporation | 1.7 | $27M | 255k | 104.53 | |
Aclaris Therapeutics (ACRS) | 1.6 | $26M | 1.0M | 25.61 | |
Shire | 1.6 | $26M | 133k | 193.86 | |
Medicines Company | 1.6 | $26M | 681k | 37.74 | |
Ardelyx (ARDX) | 1.6 | $26M | 2.0M | 12.94 | |
Eli Lilly & Co. (LLY) | 1.4 | $22M | 276k | 80.26 | |
Theravance Biopharma (TBPH) | 1.4 | $22M | 600k | 36.24 | |
Clearside Biomedical (CLSD) | 1.3 | $21M | 1.2M | 17.35 | |
Neurocrine Biosciences (NBIX) | 1.3 | $21M | 410k | 50.64 | |
Penumbra (PEN) | 1.3 | $20M | 267k | 75.99 | |
Prothena (PRTA) | 1.2 | $19M | 308k | 59.97 | |
Biogen Idec (BIIB) | 1.1 | $18M | 58k | 313.03 | |
Pacira Pharmaceuticals (PCRX) | 1.1 | $17M | 504k | 34.22 | |
Amarin Corporation (AMRN) | 1.0 | $16M | 5.0M | 3.19 | |
Amgen (AMGN) | 1.0 | $16M | 94k | 166.81 | |
Wright Medical Group Nv | 0.9 | $15M | 613k | 24.53 | |
Incyte Corporation (INCY) | 0.9 | $15M | 157k | 94.29 | |
Pra Health Sciences | 0.9 | $14M | 253k | 56.51 | |
McKesson Corporation (MCK) | 0.9 | $14M | 82k | 166.76 | |
Galapagos Nv- (GLPG) | 0.8 | $14M | 210k | 64.66 | |
Bristol Myers Squibb (BMY) | 0.8 | $14M | 250k | 53.92 | |
Jazz Pharmaceuticals (JAZZ) | 0.8 | $13M | 107k | 121.48 | |
Walgreen Boots Alliance (WBA) | 0.8 | $13M | 161k | 80.62 | |
Danaher Corporation (DHR) | 0.8 | $13M | 160k | 78.39 | |
Edwards Lifesciences (EW) | 0.8 | $12M | 103k | 120.56 | |
Coherus Biosciences (CHRS) | 0.8 | $13M | 468k | 26.78 | |
Therapeuticsmd | 0.8 | $12M | 1.8M | 6.81 | |
Dermira | 0.8 | $12M | 355k | 33.82 | |
Patheon N V | 0.7 | $12M | 400k | 29.63 | |
Retrophin | 0.7 | $12M | 522k | 22.38 | |
BioMarin Pharmaceutical (BMRN) | 0.7 | $12M | 125k | 92.52 | |
Healthsouth | 0.7 | $11M | 265k | 40.57 | |
Achillion Pharmaceuticals | 0.7 | $11M | 1.3M | 8.10 | |
Sarepta Therapeutics (SRPT) | 0.7 | $11M | 173k | 61.41 | |
Ultragenyx Pharmaceutical (RARE) | 0.7 | $10M | 147k | 70.94 | |
Hologic (HOLX) | 0.6 | $9.8M | 253k | 38.83 | |
Five Prime Therapeutics | 0.6 | $8.7M | 166k | 52.49 | |
Alkermes (ALKS) | 0.5 | $8.6M | 183k | 47.03 | |
Audentes Therapeutics | 0.5 | $8.6M | 485k | 17.81 | |
EXACT Sciences Corporation (EXAS) | 0.5 | $8.1M | 435k | 18.57 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.5 | $7.8M | 90k | 87.21 | |
Invitae (NVTAQ) | 0.5 | $7.8M | 890k | 8.76 | |
Willis Towers Watson (WTW) | 0.5 | $7.8M | 59k | 132.77 | |
Hill-Rom Holdings | 0.5 | $7.4M | 120k | 61.98 | |
Insmed (INSM) | 0.5 | $7.3M | 503k | 14.52 | |
Corvus Pharmaceuticals (CRVS) | 0.5 | $7.4M | 450k | 16.45 | |
Proteostasis Therapeutics In | 0.4 | $7.0M | 450k | 15.59 | |
Regeneron Pharmaceuticals (REGN) | 0.4 | $6.8M | 17k | 402.00 | |
Ophthotech | 0.4 | $6.8M | 148k | 46.13 | |
Beigene (BGNE) | 0.4 | $6.9M | 225k | 30.81 | |
Rigel Pharmaceuticals | 0.4 | $6.6M | 1.8M | 3.67 | |
Ligand Pharmaceuticals In (LGND) | 0.4 | $6.6M | 65k | 102.06 | |
Macrogenics (MGNX) | 0.4 | $6.7M | 225k | 29.91 | |
Egalet Corporation note 5.50% 4/1/20 | 0.4 | $6.7M | 7.8M | 0.86 | |
Envision Healthcare Hlds | 0.4 | $6.5M | 291k | 22.27 | |
Paratek Pharmaceuticals | 0.4 | $6.5M | 503k | 13.01 | |
Novadaq Technologies | 0.4 | $6.4M | 555k | 11.57 | |
Epizyme | 0.4 | $6.3M | 643k | 9.84 | |
Merus N V (MRUS) | 0.4 | $6.4M | 383k | 16.75 | |
Ascendis Pharma A S (ASND) | 0.4 | $6.0M | 300k | 20.10 | |
Alder Biopharmaceuticals | 0.4 | $6.0M | 182k | 32.77 | |
Juno Therapeutics | 0.4 | $5.9M | 197k | 30.01 | |
athenahealth | 0.4 | $5.8M | 46k | 126.12 | |
RTI Biologics | 0.4 | $5.8M | 1.9M | 3.13 | |
Endochoice Hldgs | 0.4 | $5.8M | 723k | 7.98 | |
Avexis | 0.4 | $5.8M | 140k | 41.21 | |
Intersect Ent | 0.3 | $5.5M | 345k | 15.84 | |
Compugen (CGEN) | 0.3 | $5.2M | 825k | 6.30 | |
Amicus Therapeutics (FOLD) | 0.3 | $5.1M | 695k | 7.40 | |
Aduro Biotech | 0.3 | $5.2M | 415k | 12.43 | |
Fibrogen (FGEN) | 0.3 | $4.8M | 234k | 20.70 | |
Adaptimmune Therapeutics (ADAP) | 0.3 | $4.8M | 675k | 7.05 | |
Puma Biotechnology (PBYI) | 0.3 | $4.7M | 70k | 67.05 | |
Tandem Diabetes Care | 0.3 | $4.6M | 595k | 7.66 | |
CHINA CORD Blood Corp | 0.3 | $4.5M | 880k | 5.11 | |
Clovis Oncology | 0.3 | $4.5M | 125k | 36.05 | |
Kite Pharma | 0.3 | $4.4M | 79k | 55.86 | |
Aimmune Therapeutics | 0.3 | $4.4M | 293k | 15.00 | |
BioScrip | 0.3 | $4.3M | 1.5M | 2.89 | |
Allergan Plc pfd conv ser a | 0.3 | $4.1M | 5.0k | 821.20 | |
Nivalis Therapeutics | 0.2 | $4.0M | 489k | 8.13 | |
Medpace Hldgs (MEDP) | 0.2 | $4.0M | 135k | 29.86 | |
Cardiome Pharma | 0.2 | $3.8M | 1.2M | 3.13 | |
Otonomy | 0.2 | $3.8M | 210k | 18.19 | |
Medicines Company conv | 0.2 | $3.9M | 3.0M | 1.30 | |
Innoviva (INVA) | 0.2 | $3.7M | 337k | 10.99 | |
Perrigo Company (PRGO) | 0.2 | $3.5M | 38k | 92.32 | |
Mednax (MD) | 0.2 | $3.3M | 50k | 66.26 | |
Aeglea Biotherapeutics | 0.2 | $3.4M | 524k | 6.41 | |
Nabriva Therapeutics | 0.2 | $3.0M | 426k | 7.05 | |
Intra Cellular Therapies (ITCI) | 0.2 | $2.9M | 190k | 15.24 | |
Assembly Biosciences | 0.2 | $2.8M | 390k | 7.21 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $2.9M | 250k | 11.45 | |
Steris | 0.2 | $2.9M | 40k | 73.10 | |
Dbv Technologies S A | 0.2 | $2.7M | 73k | 36.33 | |
Seres Therapeutics (MCRB) | 0.2 | $2.7M | 220k | 12.29 | |
Tetraphase Pharmaceuticals | 0.2 | $2.5M | 663k | 3.83 | |
Genocea Biosciences | 0.1 | $2.5M | 480k | 5.12 | |
Scynexis | 0.1 | $2.5M | 635k | 3.87 | |
AmSurg | 0.1 | $2.2M | 33k | 67.05 | |
Egalet | 0.1 | $2.3M | 300k | 7.61 | |
Global Blood Therapeutics In | 0.1 | $2.3M | 98k | 23.05 | |
Dimension Therapeutics | 0.1 | $2.2M | 271k | 7.99 | |
Novavax | 0.1 | $1.8M | 853k | 2.08 | |
Valeant Pharmaceuticals Int | 0.1 | $1.7M | 69k | 24.55 | |
Dynavax Technologies (DVAX) | 0.1 | $1.7M | 165k | 10.49 | |
Novocure Ltd ord (NVCR) | 0.1 | $1.8M | 214k | 8.54 | |
Exelixis (EXEL) | 0.1 | $1.6M | 125k | 12.79 | |
Anthera Pharmaceutcls | 0.1 | $1.4M | 450k | 3.15 | |
Atyr Pharma Inc Common Stock Usd 0.001 | 0.1 | $1.4M | 434k | 3.18 | |
Chiasma | 0.1 | $1.4M | 493k | 2.94 | |
Cerner Corporation | 0.1 | $1.2M | 20k | 61.75 | |
Bluebird Bio (BLUE) | 0.1 | $1.4M | 20k | 67.80 | |
Insys Therapeutics | 0.1 | $1.2M | 100k | 11.79 | |
Wright Med Group Inc note 2.000% 2/1 | 0.1 | $1.1M | 1.0M | 1.07 | |
Madrigal Pharmaceuticals (MDGL) | 0.1 | $799k | 63k | 12.68 | |
Cerulean Pharma | 0.0 | $656k | 625k | 1.05 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $421k | 270k | 1.56 | |
Orexigen Therapeutics | 0.0 | $549k | 165k | 3.32 | |
Ariad Pharmaceuticals | 0.0 | $342k | 25k | 13.68 |